Cargando…

Glipizide evaluation after a one year trial in maturity onset diabetics.

Detalles Bibliográficos
Autores principales:	Dowey, K. E., Grant, A. P., Hayes, J. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Ulster Medical Society 1979
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2385682/ https://www.ncbi.nlm.nih.gov/pubmed/553357

Ejemplares similares

SUN-185 Glipizide Induced Hepatotoxicity
por: Kamal, Palwasha, et al.
Publicado: (2019)

Preparation, Optimization and in vitro Evaluation of Glipizide Nanoparticles Integrated with Eudragit RS-100
por: Saharan, P., et al.
Publicado: (2019)

Formulation and Characterization of Mucoadhesive Buccal Films of Glipizide
por: Semalty, Mona, et al.
Publicado: (2008)

An unusual case of glipizide-induced proximal myopathy
por: Das, Saibal, et al.
Publicado: (2016)

The Physico-Chemical Properties of Glipizide: New Findings
por: Bruni, Giovanna, et al.
Publicado: (2021)

Microencapsulation Approach for Orally Extended Delivery of Glipizide: In vitro and in vivo Evaluation
por: Abdelbary, A., et al.
Publicado: (2012)

Preparation, characterization and optimization of glipizide controlled release nanoparticles
por: Emami, J., et al.
Publicado: (2014)

Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia
por: Ruan, Xu Cong, et al.
Publicado: (2019)

Case Report of Acute Pancreatitis Associated With Combination Treatment of Dulaglutide and Glipizide
por: Babajide, Oyedotun, et al.
Publicado: (2022)

In vitro Evaluation of Novel Sustained Release Microspheres of Glipizide Prepared by the Emulsion Solvent Diffusion-Evaporation Method
por: Phutane, P, et al.
Publicado: (2010)

Design, optimization and evaluation of glipizide solid self-nanoemulsifying drug delivery for enhanced solubility and dissolution
por: Dash, Rajendra Narayan, et al.
Publicado: (2015)

Development of floating chitosan-xanthan beads for oral controlled release of glipizide
por: Kulkarni, Nilesh, et al.
Publicado: (2015)

Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis
por: Qi, Cuiling, et al.
Publicado: (2014)

Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis
por: Qi, Cuiling, et al.
Publicado: (2016)

Solubility Measurement and Various Solubility Parameters of Glipizide in Different Neat Solvents
por: Kalam, Mohd Abul, et al.
Publicado: (2020)

Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
por: Hong, Jie, et al.
Publicado: (2013)

Luminol–K(3)Fe(CN)(6) chemiluminescence system for the determination of glipizide
por: Chen, Xin, et al.
Publicado: (2013)

Glycemic Control Was Unchanged in Veterans Health Administration Patients Converted from Glyburide to Glipizide
por: Aspinall, Sherrie L., et al.
Publicado: (2012)

Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency
por: Arjona Ferreira, Juan Camilo, et al.
Publicado: (2013)

The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH): Design of a pharmacogenetic Resource for Type 2 Diabetes
por: Walford, Geoffrey A., et al.
Publicado: (2015)

Preparation and in vitro Characterization of Porous Carrier–Based Glipizide Floating Microspheres for Gastric Delivery
por: Pandya, N, et al.
Publicado: (2011)

Glycemic Control and Hypoglycemia in Veterans Health Administration Patients Converted from Glyburide to Glipizide
por: Skoff, Rachel A., et al.
Publicado: (2011)

The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A retrospective analysis
por: Pantalone, Kevin M., et al.
Publicado: (2010)

Investigation of molecular aggregation mechanism of glipizide/cyclodextrin complexation by combined experimental and molecular modeling approaches
por: Huang, Tianhe, et al.
Publicado: (2019)

Pharmacokinetic Herb-Drug Interactions of Glipizide with Andrographis paniculata (Burm. f.) and Andrographolide in Normal and Diabetic Rats by Validated HPLC Method
por: Sundhani, Elza, et al.
Publicado: (2022)

EFFECT OF HERBAL COMPOUND ON MATURITY ONSET DIABETES
por: Jain, A. K., et al.
Publicado: (1987)

Glipizide sensitizes lung cancer cells to TRAIL-induced apoptosis via Akt/mTOR/autophagy pathways
por: Nazim, Uddin MD., et al.
Publicado: (2017)

Effect of raw material variability of glipizide on the in vitro dissolution rate and in vivo bioavailability performance: The importance of particle size
por: Zhao, Chenyao, et al.
Publicado: (2019)

Transdermal Glipizide Delivery System Based on Chitosan-Coated Deformable Liposomes: Development, Ex Vivo, and In Vivo Studies
por: Badran, Mohamed M., et al.
Publicado: (2022)

Maturity-Onset Diabetes of the Young Identified Among Algerian Probands with Early-Onset Diabetes
por: Bouldjennet, Faiza, et al.
Publicado: (2020)

Recognition of maturity‐onset diabetes of the young in China
por: Liang, Hua, et al.
Publicado: (2020)

The Clinical Characteristics and Gene Mutations of Maturity-Onset Diabetes of the Young Type 5 in Sixty-One Patients
por: Ge, Shenghui, et al.
Publicado: (2022)

Maturity Onset Diabetes of the Young Masquerading as New Onset Diabetes Mellitus Type 1
por: Miller, Assia, et al.
Publicado: (2021)

A Post Hoc Analysis of HbA1c, Hypoglycemia, and Weight Change Outcomes with Alogliptin vs Glipizide in Older Patients with Type 2 Diabetes
por: Bron, Morgan, et al.
Publicado: (2014)

Characteristics of maturity onset diabetes of the young in a large diabetes center
por: Chambers, Christina, et al.
Publicado: (2015)

Advanced and multifaceted stability profiling of the first-line antidiabetic drugs metformin, gliclazide and glipizide under various controlled stress conditions
por: Gedawy, Ahmed, et al.
Publicado: (2020)

Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial
por: Nauck, Michael A., et al.
Publicado: (2011)

VARIATIONS IN THE PROGENESIS OF MATURITY ONSET DIABETES ACCORDING TO BODY CONSTITUTION
por: Chandola, H.M., et al.
Publicado: (1994)

Clinical features and treatment of maturity onset diabetes of the young (MODY)
por: Gardner, Daphne SL, et al.
Publicado: (2012)

Maturity onset diabetes of the young and fibrin-related thrombosis risk
por: Sagar, RC, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6jhns5at6rnv8i3ktl6fciivsa